Logo image of SOND

SONDER HOLDINGS INC (SOND) Stock Fundamental Analysis

NASDAQ:SOND - US83542D3008 - Common Stock

1.92 USD
+0.07 (+3.78%)
Last: 8/29/2025, 8:00:02 PM
Fundamental Rating

1

Overall SOND gets a fundamental rating of 1 out of 10. We evaluated SOND against 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of SOND have multiple concerns. SOND is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SOND has reported negative net income.
In the past year SOND has reported a negative cash flow from operations.
In the past 5 years SOND always reported negative net income.
In the past 5 years SOND always reported negative operating cash flow.
SOND Yearly Net Income VS EBIT VS OCF VS FCFSOND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

SOND has a worse Return On Assets (-26.49%) than 95.52% of its industry peers.
Industry RankSector Rank
ROA -26.49%
ROE N/A
ROIC N/A
ROA(3y)-16.85%
ROA(5y)-77.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SOND Yearly ROA, ROE, ROICSOND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

SOND has a Gross Margin of 38.24%. This is in the lower half of the industry: SOND underperforms 65.67% of its industry peers.
In the last couple of years the Gross Margin of SOND has declined.
The Profit Margin and Operating Margin are not available for SOND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.95%
GM growth 5Y-15.13%
SOND Yearly Profit, Operating, Gross MarginsSOND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

SOND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOND has more shares outstanding
The number of shares outstanding for SOND has been increased compared to 5 years ago.
SOND has a worse debt/assets ratio than last year.
SOND Yearly Shares OutstandingSOND Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SOND Yearly Total Debt VS Total AssetsSOND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -2.08, we must say that SOND is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SOND (-2.08) is worse than 94.03% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.08
ROIC/WACCN/A
WACC2.62%
SOND Yearly LT Debt VS Equity VS FCFSOND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SOND has a Current Ratio of 0.22. This is a bad value and indicates that SOND is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SOND (0.22) is worse than 94.78% of its industry peers.
SOND has a Quick Ratio of 0.22. This is a bad value and indicates that SOND is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SOND (0.22) is worse than 92.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
SOND Yearly Current Assets VS Current LiabilitesSOND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.21% over the past year.
The Revenue has been growing slightly by 3.20% in the past year.
Measured over the past years, SOND shows a very strong growth in Revenue. The Revenue has been growing by 34.17% on average per year.
EPS 1Y (TTM)24.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.5%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y38.69%
Revenue growth 5Y34.17%
Sales Q2Q%-1.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 13.73% on average over the next years. This is quite good.
EPS Next Y38.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.62%
Revenue Next 2Y16.83%
Revenue Next 3Y15.72%
Revenue Next 5Y13.73%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SOND Yearly Revenue VS EstimatesSOND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
SOND Yearly EPS VS EstimatesSOND Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SOND. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SOND. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SOND Price Earnings VS Forward Price EarningsSOND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOND Per share dataSOND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONDER HOLDINGS INC

NASDAQ:SOND (8/29/2025, 8:00:02 PM)

1.92

+0.07 (+3.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-03 2025-11-03
Inst Owners29.89%
Inst Owner Change28.12%
Ins Owners7.74%
Ins Owner Change33.51%
Market Cap25.56M
Analysts43.33
Price TargetN/A
Short Float %10.93%
Short Ratio7.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.02%
Min Revenue beat(2)-19.88%
Max Revenue beat(2)-18.15%
Revenue beat(4)0
Avg Revenue beat(4)-15.13%
Min Revenue beat(4)-19.88%
Max Revenue beat(4)-5.97%
Revenue beat(8)2
Avg Revenue beat(8)-8.12%
Revenue beat(12)5
Avg Revenue beat(12)-2.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.41
EYN/A
EPS(NY)-6.83
Fwd EYN/A
FCF(TTM)-9.67
FCFYN/A
OCF(TTM)-9.57
OCFYN/A
SpS46.82
BVpS-40.34
TBVpS-40.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.24%
FCFM N/A
ROA(3y)-16.85%
ROA(5y)-77.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.95%
GM growth 5Y-15.13%
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.72%
Cap/Sales 0.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -2.08
F-Score2
WACC2.62%
ROIC/WACCN/A
Cap/Depr(3y)61.33%
Cap/Depr(5y)69.46%
Cap/Sales(3y)2.79%
Cap/Sales(5y)5.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.5%
EPS Next Y38.61%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y38.69%
Revenue growth 5Y34.17%
Sales Q2Q%-1.2%
Revenue Next Year17.62%
Revenue Next 2Y16.83%
Revenue Next 3Y15.72%
Revenue Next 5Y13.73%
EBIT growth 1Y32.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.94%
EBIT Next 3Y46.56%
EBIT Next 5Y32.66%
FCF growth 1Y-12.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.64%
OCF growth 3YN/A
OCF growth 5YN/A